Arnold Reuser

12.0k total citations · 1 hit paper
190 papers, 8.3k citations indexed

About

Arnold Reuser is a scholar working on Physiology, Rheumatology and Organic Chemistry. According to data from OpenAlex, Arnold Reuser has authored 190 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Physiology, 106 papers in Rheumatology and 68 papers in Organic Chemistry. Recurrent topics in Arnold Reuser's work include Lysosomal Storage Disorders Research (157 papers), Glycogen Storage Diseases and Myoclonus (106 papers) and Carbohydrate Chemistry and Synthesis (68 papers). Arnold Reuser is often cited by papers focused on Lysosomal Storage Disorders Research (157 papers), Glycogen Storage Diseases and Myoclonus (106 papers) and Carbohydrate Chemistry and Synthesis (68 papers). Arnold Reuser collaborates with scholars based in Netherlands, United States and United Kingdom. Arnold Reuser's co-authors include Ans T. van der Ploeg, Marian A. Kroos, H. Galjaard, A. T. Hoogeveen, M M Hermans, Pieter A. van Doorn, Marianne Hoogeveen‐Westerveld, Rob Willemsen, H.A. Wisselaar and M.L.C. Hagemans and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Arnold Reuser

188 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pompe's disease

2008 537 citations Ans T. van der Ploeg, Arnold Reuser profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arnold Reuser Netherlands	52	6.2k	4.0k	2.5k	2.1k	1.3k	190	8.3k
David A. Wenger United States	55	6.4k 1.0×	525 0.1×	4.1k 1.7×	1.5k 0.7×	1.8k 1.4×	221	9.2k
Steven U. Walkley United States	44	4.3k 0.7×	496 0.1×	2.0k 0.8×	969 0.5×	1.3k 1.0×	109	6.3k
M. Elleder Czechia	32	2.7k 0.4×	628 0.2×	1.4k 0.6×	570 0.3×	885 0.7×	194	4.1k
K. Harzer Germany	34	3.1k 0.5×	382 0.1×	2.2k 0.9×	785 0.4×	816 0.6×	167	4.5k
Gideon Bach Israel	35	1.6k 0.3×	370 0.1×	1.2k 0.5×	442 0.2×	538 0.4×	113	3.9k
Sergei A. Grando United States	57	445 0.1×	1.6k 0.4×	3.6k 1.4×	254 0.1×	294 0.2×	151	7.8k
John W. Callahan Canada	34	1.8k 0.3×	200 0.1×	1.8k 0.7×	417 0.2×	425 0.3×	125	3.9k
Xingxuan He United States	34	2.0k 0.3×	179 0.0×	2.4k 1.0×	377 0.2×	588 0.5×	63	4.3k
J S O′Brien United States	33	2.5k 0.4×	175 0.0×	1.7k 0.7×	520 0.2×	305 0.2×	82	3.9k
Ikuo Goto Japan	38	1.2k 0.2×	297 0.1×	1.6k 0.6×	144 0.1×	336 0.3×	170	4.2k

Countries citing papers authored by Arnold Reuser

Since Specialization

Citations

This map shows the geographic impact of Arnold Reuser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Reuser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Reuser more than expected).

Fields of papers citing papers by Arnold Reuser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold Reuser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Reuser. The network helps show where Arnold Reuser may publish in the future.

Co-authorship network of co-authors of Arnold Reuser

This figure shows the co-authorship network connecting the top 25 collaborators of Arnold Reuser. A scholar is included among the top collaborators of Arnold Reuser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold Reuser. Arnold Reuser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Capelle, Carine I. van, Jan C. van der Meijden, Johanna M. P. van den Hout, et al.. (2016). Childhood Pompe disease: clinical spectrum and genotype in 31 patients. Orphanet Journal of Rare Diseases. 11(1). 65–65. 47 indexed citations

Güngör, Deniz, Michelle E. Kruijshaar, Iris Plug, et al.. (2015). Quality of Life and Participation in the Daily Life (Activities) of Adults with Pompe Disease Receiving Enzyme Replacement Therapy: 10 Years of International Follow-Up. Journal of Neuromuscular Diseases. 2(s1). S63–S63. 1 indexed citations

Brands, Marion M., Ronald R. de Krijger, Ad J.J.C. Bogers, et al.. (2013). Macrophage involvement in mitral valve pathology in mucopolysaccharidosis type VI (Maroteaux–lamy syndrome). American Journal of Medical Genetics Part A. 161(10). 2550–2553. 5 indexed citations

Ruijter, George J. G., A. M. Boer, Jackie Bosch, et al.. (2013). Newborn Screening for Hunter Disease: A Small-Scale Feasibility Study. JIMD Reports. 14. 23–27. 16 indexed citations

Beek, Nadine A. M. E. van der, Juna M. de Vries, M.L.C. Hagemans, et al.. (2012). Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. Orphanet Journal of Rare Diseases. 7(1). 88–88. 111 indexed citations

Kroos, Marian A., Marianne Hoogeveen‐Westerveld, Ans van der Ploeg, & Arnold Reuser. (2012). The genotype–phenotype correlation in Pompe disease. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 160C(1). 59–68. 93 indexed citations

Oussoren, Esmée, Marion M. Brands, George J. G. Ruijter, Ans T. van der Ploeg, & Arnold Reuser. (2011). Bone, joint and tooth development in mucopolysaccharidoses: Relevance to therapeutic options. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(11). 1542–1556. 77 indexed citations

Zandbergen, Adrienne A.M., Carine I. van Capelle, Juna M. de Vries, et al.. (2010). Low bone mass in Pompe disease. Bone. 47(3). 643–649. 49 indexed citations

Capelle, Carine I. van, Léon P. F. Winkel, M.L.C. Hagemans, et al.. (2008). Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease. Neuromuscular Disorders. 18(6). 447–452. 73 indexed citations

10.

Hagemans, M.L.C., et al.. (2007). M.P.2.06 Gradual disease progression during long-term follow up of patients with late-onset Pompe disease. Neuromuscular Disorders. 17(9-10). 794–794. 1 indexed citations

11.

Hagemans, M.L.C., et al.. (2007). Enzymatic replacement therapy with rhGAA in Brazilian Pompe patients. Neuromuscular Disorders. 17(9). 887.

12.

Drost, Maarten R., Gert Schaart, Paul van Dijk, et al.. (2007). Both type 1 and type 2a muscle fibers can respond to enzyme therapy in Pompe disease. Muscle & Nerve. 37(2). 251–255. 19 indexed citations

13.

Bodamer, Olaf A., Dorothea Haas, M M Hermans, Arnold Reuser, & Georg F. Hoffmann. (2002). l-alanine supplementation in late infantile glycogen storage disease type II. Pediatric Neurology. 27(2). 145–146. 21 indexed citations

14.

Bijvoet, A. G. A., Marian A. Kroos, Frank Pieper, et al.. (1996). Expression of cDNA-encoded human acid α-glucosidase in milk of transgenic mice. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1308(2). 93–96. 23 indexed citations

15.

Reuser, Arnold, Marian A. Kroos, M M Hermans, et al.. (1995). Glycogenosis type II (acid maltase deficiency). Muscle & Nerve. 18(S14). S61–S69. 132 indexed citations

16.

Wokke, John H. J., Margreet G.E.M. Ausems, Marie‐José H. van den Boogaard, et al.. (1995). Genotype‐phenotype correlation in adult‐onset acid maltase deficiency. Annals of Neurology. 38(3). 450–454. 60 indexed citations

17.

Bakker, Cathy, Esther de Graaff, J. L. M. Keulemans, et al.. (1993). Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature. 363(6431). 722–724. 276 indexed citations

18.

Ploeg, Ans T. van der, Marian A. Kroos, Rob Willemsen, Nicolaas H. C. Brons, & Arnold Reuser. (1991). Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice.. Journal of Clinical Investigation. 87(2). 513–518. 63 indexed citations

19.

Ploeg, Ans T. van der, Rob Willemsen, Marian A. Kroos, et al.. (1990). Rat Heart Perfusion as Model System for Enzyme Replacement Therapy in Glycogenosis Type II. Pediatric Research. 28(4). 344–347. 10 indexed citations

20.

Dongen, Jacques J. M. van, Rob Willemsen, Edward I. Ginns, et al.. (1985). The subcellular localization of soluble and membrane-bound lysosomal enzymes in I-cell fibroblasts: a comparative immunocytochemical study.. PubMed. 39(1). 179–89. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact